SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TechCreate Group Ltd. - Ordinary Shares - Class A

TechCreate Group Ltd. (TCGL) is experiencing an explosive, multi-thousand percent surge, triggering a massive short squeeze and sparking widespread community discussion as retail traders celebrate immense gains while others warn of a volatile pump reminiscent of past low-float "Singapore" or "Chinese" plays.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is actively discussed after its latest earnings report significantly surpassed expectations, driven by record iPhone and services revenue, robust growth in China, and a strong Q2 forecast. While some in the community express frustration over the stock's muted immediate reaction, labeling it an 'option killer,' others anticipate a delayed rally given the company's strong performance and ongoing focus on future innovation and AI initiatives.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp is surging following an impressive earnings report and robust guidance, which bulls attribute to an ongoing re-rating driven by insatiable AI and data center memory demand. This has ignited heated debate within the community, with many anticipating continued upside while a strong bearish contingent cautions that the rapid ascent represents an unsustainable bubble.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending amidst swirling rumors of a potential merger with SpaceX and/or xAI, sparking intense debate among investors who are either bullish on the creation of a massive, synergistic tech empire or highly skeptical, viewing it as a desperate maneuver to pump a struggling stock.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending with high anticipation and anxiety ahead of its earnings report, where the community is debating whether strong results and guidance can overcome recent dilution concerns and drive a rebound in the stock.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending following a significant theft and subsequent dumping of 2.05 million LTC, which has created a stark divide in the community; bulls are aggressively buying, believing the "digital silver" is undervalued and poised for a major rebound, while bears emphasize its continued underperformance against Bitcoin.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as President Trump's aggressive trade policies, geopolitical ambitions like Greenland, and public criticism of the Federal Reserve are igniting fervent debate among investors over US fiscal health and the future direction of bond yields.

Virtuix Holdings, Inc.is a technology and entertainment company. It focuses on developing virtual reality (VR) hardware and software. The company was founded by Jan Goetgeluk on December 20, 2013 and is headquartered in Austin, TX.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix Holdings Inc. (VTIX) is capturing market attention following its recent direct listing, sparking intense debate among traders regarding its extreme volatility and potential for a massive short squeeze, driven by a reportedly low float and comparisons to past high-flying meme stocks.

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.

Adlai Nortye Ltd. - ADR

Adlai Nortye Ltd. American

Adlai Nortye Ltd. (ANL) is buzzing after announcing an exclusive licensing agreement for its pan-RAS inhibitor AN9025, a deal potentially worth up to $230 million with an upfront payment. This news has ignited significant after-hours trading and bullish price targets, as the community actively speculates on ANL's potential for a multi-day run, drawing comparisons to other volatile Chinese small-cap biotech plays.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors react to its latest earnings, focusing on increased AI capital expenditures and a slight deceleration in Azure growth, prompting "sell the news" profit-taking. The community is actively debating if current AI costs outweigh future revenue, with many viewing the dip as an overreaction and a long-term buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Campbell & CO Investment Adviser LLC Lowers Holdings in Edgewise Therapeutics, Inc. $EWTX

Campbell & CO Investment Adviser LLC trimmed its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 90.2% during the 3rd quarter, according to its most recent disclosure with the...

Edgewise Therapeutics (NASDAQ:EWTX) Director Sells $3,399,466.24 in Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Badreddin Edris sold 115,471 shares of the business's stock in a transaction that occurred on Wednesday, January 21st. The shares...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eleven analysts that are covering the stock, Marketbeat.com...

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 6.4% - Time to Sell?

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 6.4% - Should You Sell...

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 7% - Should You Buy?

Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7% - Here's Why...

Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026

Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026 Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026 PR Newswire BOULDER, Colo...

Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on...

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules PR Newswire BOULDER...

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - Here's What Happened

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - What's Next...

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits

Key PointsCalifornia-based Foresite Capital Management VI sold 585,000 shares of Edgewise Therapeutics in the third quarter...

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.44	--	--	N/A
Q3 '25	-$0.40	-$0.39	1.86%	BEAT
Q2 '25	-$0.41	-$0.34	17.91%	BEAT
Q1 '25	-$0.43	-$0.43	-0.45%	MISSED
Q4 '24	-$0.42	-$0.42	-0.68%	MISSED

EWTX
Edgewise Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest EWTX News

EWTXEdgewise Therapeutics Inc